(Total Views: 532)
Posted On: 12/12/2021 2:16:00 PM
Post# of 154883
Any evidence that Big Pharma had offered us partnership for LH and Nader turned it down? Or it's only your imagination?
_______________
But as an example, if we had partnered with a Big Pharma (i.e. Merck, Eli Lily, Roche, etc....someone who would be a competitor to Gilead) last year March 2020 for COVID (excluding Long Haulers, as that wasn't known, and is really it's own unique pathology) we would have had the pull and the resources to have a larger trial and a more appropriate protocol, as we now have in Brazil. Subgroup data could have even pulled off an EUA if we had a true partner, especially if we had one of them running the trials, not us, so basically we just collect the paychecks when it's done.
Read More: https://investorshangout.com/post/view?id=629...z7ErUqeaRI
_______________
But as an example, if we had partnered with a Big Pharma (i.e. Merck, Eli Lily, Roche, etc....someone who would be a competitor to Gilead) last year March 2020 for COVID (excluding Long Haulers, as that wasn't known, and is really it's own unique pathology) we would have had the pull and the resources to have a larger trial and a more appropriate protocol, as we now have in Brazil. Subgroup data could have even pulled off an EUA if we had a true partner, especially if we had one of them running the trials, not us, so basically we just collect the paychecks when it's done.
Read More: https://investorshangout.com/post/view?id=629...z7ErUqeaRI
(0)
(1)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
